DOCSLIB.ORG

CUA Guideline: the Workup and Management of Azoospermic Males

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
CUA Guideline: the Workup and Management of Azoospermic Males Originalcua guideline research CUA Guideline: The workup and management of azoospermic males Keith Jarvi, MD, FRCSC;* Kirk Lo, MD, FRCSC;* Ethan Grober, MD;* Victor Mak, MD, FRCSC;* Anthony Fischer, MD, FRCSC;¥ John Grantmyre, MD, FRCSC;± Armand Zini, MD, FRCSC;+ Peter Chan, MD, FRCSC;+ Genevieve Patry, MD, FRCSC;£ Victor Chow, MD, FRCSC;§ Trustin Domes, MD, FRCSC# *Department of Urology, Mount Sinai Hospital, University of Toronto, Toronto, ON; ¥Division of Urology, McMaster University, Hamilton, ON; ±Department of Urology, Dalhousie University, Halifax, NS; +Division of Urology, McGill University Health Centre, Montreal, QC; £Hôtel-Dieu De Lévis, Lévis, QC; §Department of Urologic Sciences, University of British Columbia, Vancouver, BC; #Saskatoon Health Region, Saskatoon, SK Cite as: Can Urol Assoc J 2015;9(7-8):229-35. http://dx.doi.org/10.5489/cuaj.3209 A further group of men have a failure to ejaculate. These Published online August 10, 2015. may be men with spinal cord injury, psychogenic failure to ejaculate, or neurological damage (sympathetic nerve committee was established at the request of the damage from, for example, a retroperitoneal lymph node Canadian Urological Association to develop guide- dissection). A lines for the investigation and management of azo- To understand the management of azoospermia, it is ospermia. Members of the committee, all of whom have important to also understand the role of assisted reproduc- special expertise in the investigation and management of tive technologies (ARTs) (i.e., in-vitro fertilization) in the male infertility, were chosen from different communities treatment of azoospermia. Since the 1970s, breakthroughs across Canada. The members represent different practices in the ARTs have allowed us to offer potentially successful in different communities. treatments for up to 98% of couples with male factor infer- tility.6 These significant advances had little to do with tech- Introduction and background niques to improve the sperm quality, but relied on the use of ARTs to “treat” the male infertility. These programs used Infertility or subfertility affects 15% of couples in Canada, techniques to increase the number of mature eggs produced with a male factor contributing to the fertility problem in by the women by manipulating the hormonal environment close to 50% of these couples. Of the men presenting for in the women using exogenous hormones (ovulation induc- fertility investigation, up to 20% are found to be azoosper- tion) then used either: mic. These men can be categorized as having either: 1) Timed insemination to optimize the pregnancy rates 1) Pre-testicular azoospermia (2% of men with azo- either through intercourse or intra-uterine insemina- ospermia); tion of the partners washed sperm; a) Due to a hypothalamic or pituitary abnormal- 2) In-vitro fertilization (IVF); or oocytes are retrieved ity (diagnosed with hypo-gonadotropic-hypo- from the ovaries then are either incubated with the gonadism). sperm in a dish; or 2) Testicular failure or non-obstructive azoospermia 3) Intra-cytoplasmic sperm injection (ICSI), by inject- (49%–93% of men with azoospermia); or ing the sperm directly into the cytoplasm of the a) While the term testicular failure would seem to oocyte. indicate a complete absence of spermatogen- All of the above techniques are widely used to treat esis, men with testicular failure actually have couples with male factor infertility. In the United States either reduced spermatogenesis, maturation in 2012, over 165 000 IVF/ICSI cycles were performed. 7 arrest or a complete failure of spermatogenesis Worldwide the numbers of IVF/ICSI cycles were high. In noted with Sertoli-cell only syndrome.1-5 2013, the International Committee for Monitoring Assisted 3) Post-testicular causes for azoospermia (7%–51% of Reproductive Technology reported that in 2004 there were men with azoospermia). 954 743 IVF or ICSI cycles worldwide, with 237 809 babies a) Obstruction or ejaculatory dysfunction. born.8 b) Normal spermatogenesis but obstructive azo- Using ICSI, it is now possible to produce a pregnancy ospermia or ejaculatory dysfunction.1-5 with any live sperm (motile or not), from either the semen CUAJ • July-August 2015 • Volume 9, Issues 7-8 229 © 2015 Canadian Urological Association Jarvi et al. or any site within the male reproductive tract. Even men If the man has had exposure to any of the gonadotoxic with azoospermia can be offered sperm retrieval with ICSI. agents (Table 1), he should be taken off these medications Sperm could be retrieved from any site in the reproductive and his semen should be retested in 3 to 6 months. If the tract and used for ICSI. These are the men who previously man has had a recent serious medical illness or injury or had very limited chances to ever have biologically related he has evidence of a recent reproductive tract infection, children. Pregnancy rates of close to 50% per cycle of ICSI semen testing should be repeated at least 3 months follow- (women under 35 years of age) are expected, with the preg- ing recovery from the illness. nancy rates independent of the site of the origin of the sperm.6 The initial investigations will depend on the information obtained from the history and physical examination, in addi- History, physical exam and initial investigations for tion to the results of the semen analyses. men with azoospermia Azoospermia with reduced semen volume After at least two semen analyses have confirmed azoosper- If the semen volume is reduced (<1.5 mL) and documented mia, the men should be investigated with a thorough history on repeat testing, careful questioning should elicit whether (Table 1) and physical examination (Table 2). Most men will this is an artifact (i.e., missed the container, difficulty provid- also require laboratory and imaging studies. ing specimen) or truly a low semen volume.9 Since most of the semen comes from the seminal vesicles and prostate (>90%), low semen volume means that either: Table 1. Type of information to gather during a patient’s 1) the seminal vesicles are abnormal or obstructed; history 2) the ejaculatory ducts are obstructed; or General information Examples and areas of focus 3) there is an ejaculatory dysfunction (either failure of 1. Infertility history • Duration of infertility • Whether the infertility is emission or retrograde ejaculation). primary or secondary Physical examination will help determine if the vas def- • Any treatments to date erens is present in the scrotum. Absence of the vas deferens • Libido in the scrotum is usually associated with absence of the • Sexual function seminal vesicles and is a cause for low semen volume and • Sexual activity azoospermia. 2. The general health of the man • Diabetes; • Respiratory issues The first laboratory test is to determine if there is retro- • Recent illnesses grade ejaculation by testing the post-ejaculate urine for the 3. Any proven or suspected genito- • Sexually transmitted presence of sperm. The presence of any sperm in the urine, urinary infections, testicular infections post-ejaculation in men with azoospermia, is diagnostic of infections or inflammation8 • Epididymo-orchitis retrograde ejaculation. Since retrograde ejaculation may be • Mumps orchitis due to a failure of the bladder neck to close with orgasm, 4. Any surgery of the reproductive • Testis cancer use of an alpha agonist (pseudoephedrine or other alpha tract • Undescended testis • Hydrocelectomies agonist) before ejaculation may close the bladder neck and • Spermatocelectomies convert retrograde into ante-grade ejaculation. Diabetic men • Varicocelectomies often have retrograde ejaculation or failure of emission.10 • Vasectomies If there is no evidence of retrograde ejaculation, diagnos- 5. Exposure to medications • Hormone/steroid therapy tic imaging of the reproductive tract is usually required to and therapies which might • Antibiotics (sulphasalazine) have an adverse impact on • Alpha-blockers spermatogenesis • 5-alpha-reductase Table 2. Type of information to gather during a patient’s inhibitors physical examination • Chemotherapeutic agents Type of examination Examples and areas of focus • Radiation 1. State of virilization • Finasteride9 2. Scrotal examination • Size and consistency of the • Narcotics testis 6. Environmental exposures • Pesticides • Presence and grade of • Excessive heat on the varicoceles testicles • Palpable vas deferens 7. Any recreational drugs • Marijuana 3. Abdominal examination • Presence of scars in the • Excessive alcohol inguinal area indicative 8. History of any genetic of previous inguinal abnormalities in the patient or surgery or treatment of his family undescended testis. 230 CUAJ • July-August 2015 • Volume 9, Issues 7-8 azoospermic males identify reproductive tract obstruction or abnormalities. A Normal semen volume azoospermia transrectal ultrasound (TRUS) will determine if the seminal vesicles and vas deferens close to the prostate are normal. As stated above, the categories of azoospermia are: Obstruction of the ejaculatory duct is usually detected by a 1) Pre-testicular azoospermia; TRUS and is usually accompanied by dilation of the seminal 2) Testicular failure or non-obstructive azoospermia; vesicles (typically >1.5 cm wide).11 If absence of the vas and deferens and/or the seminal vesicle is identified, the man has 3) Post-testicular obstruction.1-5 about an 80% chance of carrying a genetic alteration associ- The category of azoospermia may often be determined by ated with cystic fibrosis.12 Cystic fibrosis
Load more

Recommended publications
  • Impact of Infection on the Secretory Capacity of the Male Accessory Glands
    Clinical�������������� Urolo�y Infection and Secretory Capacity of Male Accessory Glands International Braz J Urol Vol. 35 (3): 299-309, May - June, 2009 Impact of Infection on the Secretory Capacity of the Male Accessory Glands M. Marconi, A. Pilatz, F. Wagenlehner, T. Diemer, W. Weidner Department of Urology and Pediatric Urology, University of Giessen, Giessen, Germany ABSTRACT Introduction: Studies that compare the impact of different infectious entities of the male reproductive tract (MRT) on the male accessory gland function are controversial. Materials and Methods: Semen analyses of 71 patients with proven infections of the MRT were compared with the results of 40 healthy non-infected volunteers. Patients were divided into 3 groups according to their diagnosis: chronic prostatitis NIH type II (n = 38), chronic epididymitis (n = 12), and chronic urethritis (n = 21). Results: The bacteriological analysis revealed 9 different types of microorganisms, considered to be the etiological agents, isolated in different secretions, including: urine, expressed prostatic secretions, semen and urethral smears: E. Coli (n = 20), Klebsiella (n = 2), Proteus spp. (n = 1), Enterococcus (n = 20), Staphylococcus spp. (n = 1), M. tuberculosis (n = 2), N. gonorrhea (n = 8), Chlamydia tr. (n = 16) and, Ureaplasma urealyticum (n = 1). The infection group had significantly (p < 0.05) lower: semen volume, alpha-glucosidase, fructose, and zinc in seminal plasma and, higher pH than the control group. None of these parameters was sufficiently accurate in the ROC analysis to discriminate between infected and non- infected men. Conclusion: Proven bacterial infections of the MRT impact negatively on all the accessory gland function parameters evaluated in semen, suggesting impairment of the secretory capacity of the epididymis, seminal vesicles and prostate.
    [Show full text]
  • Chronic Pelvic Pain Syndrome in Men
    Chronic Pelvic Pain Syndrome in Men Diagram of the male genital tract showing the pelvic floor anatomy and how it is linked to the urinary tract with the urethra passing through it (external urethral sphincter). The pelvic floor therefore helps control how we pass water (urinate). (See resources at end for links to images of pelvic floor muscles and prostate.) SUMMARY Chronic pelvic pain syndrome (CPPS) and chronic prostatitis (CP) in men are often terms used to describe a condition which causes pain in the lower pelvic region of men. Symptoms are thought to come from the prostate gland or increased muscle tension around the pelvic floor. Our experience at Unity indicates that ¾ (75%) of men will have a significant improvement in their symptoms, with best results achieved by: 1) Ruling out underlying infection and excluding cancer in those who are worried about these being the cause 2) Having a detailed discussion so that you understand the complex mechanisms which can cause pelvic pain 3) Some treatments including alpha blockers, antibiotics, and sometimes painkillers 4) Pelvic floor muscle relaxation techniques 5) Psychological support/therapy in order to reduce pelvic floor muscle tension and improve strategies for coping with the pain, help you address your underlying worries and concerns and identify and reduce possible sources of stress. Vs3 31/03/2020 1 What is Chronic Pelvic Pain Syndrome? Chronic pelvic pain syndrome (CPPS) can occur in both men and women. It is sometimes also called chronic prostatitis (CP) in men. This leaflet deals with CPPS in men. CPPS/CP is an ongoing (persistent or recurrent > 3 of the last 6 months) discomfort or pain that you feel in your lower pelvic region - mainly at the base or tip of your penis, and/or your testicles and/or around your back passage (anus) for which no cause has been found.
    [Show full text]
  • 5Α-Reductase Deficiency, 173, 175 Acrosomal Response to Ionophore
    Cambridge University Press 978-0-521-88109-8 - Surgical and Medical Management of Male Infertility Marc Goldstein and Peter N. Schlegel Index More information Index 5α-reductase deficiency,173 , 175 antioxidant therapy, 187–9 genetic testing, 20–2, children, 271–2 acrosomal response to ionophore carnitine, 188 162 experimental methods, 272 challenge (ARIC) score, carotenoids, 188 preoperative preparation, gonadal protection with 15 folate, 188 162–3 hormonal suppression, 271 acrosome, 4–5 lycopene, 188 treatment considerations, gonadal shielding with acrosome reaction assays, N-acetylcysteine (NAC), 188 163 radiotherapy, 271 14–15 selenium, 189 obstructive, 19, 61–2, nursing issues, 326–7 acupuncture, 190 vitamin C, 187–8 See also epididymal sperm sperm banking, 271, 281–4 adenohypophysis, 1 vitamin E, 188 aspiration fertility treatment after cancer adolescents. See also pediatric anti-retroviral drugs, 289 evaluation, 100 therapy, 272–3 issues antisperm antibodies, 234, sperm retrieval, 101–3 pediatric, 264 fertility preservation issues, See also autoimmunity to testicular biopsy, 61 treatment effects on 271 spermatozoa 27–8 azoospermic factor (AZF) region, fertility, 269–70, 285, varicocele, 262–3 cystic fibrosis and,29–30 5, 21 See also chemotherapy; agenesis, seminal vesicles, 48–50 effects on fertility,28–9 AZFa, 20 radiotherapy aging, 2 routine testing for, 33, 234 AZFb, 20 anatomical obstruction, 269 AIDS, 197–8 antral follicle count, 222 AZFc, 20, 22 hormonal and gonadotoxic alcohol abuse, 9, 189 anxiety, sexual dysfunction and,
    [Show full text]
  • How to Investigate Azoospermia in Stallions
    NON-PREGNANT MARE AND STALLION How to Investigate Azoospermia in Stallions Terry L. Blanchard, DVM, MS, Diplomate ACT; Steven P. Brinsko, DVM, MS, PhD, Diplomate ACT; Dickson D. Varner, DVM, MS, Diplomate ACT; and Charles C. Love, DVM, PhD, Diplomate ACT Authors’ address: Department of Large Animal Medicine and Surgery, College of Veterinary Medicine, Texas A&M University, College Station, Texas 77843-4475; e-mail: stalliondoc@ gmail.com. © 2009 AAEP. 1. Introduction did not ejaculate.3 A number of reports describe In a review of ejaculatory dysfunction, McDonnell1 therapy indicated for ejaculation failure, but they reported that ϳ25% of stallions referred to a fertility are not the subject of this report. Briefly, they in- clinic had evidence of ejaculatory problems. The clude breeding and/or pharmacological management vast majority of cases were anejaculatory (failure to to increase sexual stimulation before and during the ejaculate). Less than 1% of horses in that survey breeding process, treatment and/or breeding man- were truly azoospermic (i.e., ejaculated seminal flu- agement to minimize potential musculoskeletal pain ids devoid of sperm). Failure to ejaculate sperm that could interrupt the emission and ejaculatory can be a troublesome problem that requires accurate process, and pharmacologic manipulation to lower diagnosis, determination of prognosis for correction the threshold to emission and ejaculation.1–3 Tech- (sometimes necessitating retirement as a breeding niques used to manage repeated ejaculatory failure stallion), and arduous treatment and/or breeding can be arduous and time consuming, and they are management to correct.2,3 Figure 1 represents an reviewed by Varner et al.3 attempt at a schematic overview of an approach to When breeding behavior and apparent ejaculation diagnosis of lack of sperm in ejaculates.
    [Show full text]
  • Ejaculation Problems3 9
    1 6 Fact Sheet 7 12 2 8 11 Ejaculation Problems3 9 4 10 5 What is ejaculation? 1 Bladder 2 Vas deferens Ejaculation is the release of semen from the penis 3 Urethra at orgasm (sexual climax). When a man is sexually 1 stimulated, the brain sends signals to the genital 6 4 Penis area through nerves in the spinal cord to make the 5 Scrotum 7 12 pelvic muscles contract. 2 8 6 Seminal vesicle 11 7 Rectum At orgasm, waves of muscle contractions transport 3 the sperm, with a small amount of fluid, from the 8 Prostate gland testes through to the vas deferens. The seminal 9 9 Epididymis vesicles and prostate contribute extra fluid to 4 10 Testicle protect the sperm. 10 11 Cowper’s gland 5 This mixture of sperm and fluid (semen) travels 12 Ejaculatory duct along the urethra to the tip of the penis where it is ejaculated (released). What are ejaculation problems? More details about premature ejaculation can be found in a separate1 Bladder Andrology Australia fact Men can experience different kinds of ejaculation sheet. 2 Vas deferens problems, including: 3 Urethra The other ejaculation4 Penis problems are less common • premature ejaculation than premature ejaculation5 Scrotum but can also cause distress for the man and his partner. • retrograde ejaculation 6 Seminal vesicle 7 Rectum • delayed ejaculation (or no ejaculation) What causes ejaculation problems? 8 Prostate gland • painful ejaculation. Ejaculation problems9 Epididymis can have a variety of 10 Testicle How common are ejaculation causes, both physical and psychological. Physical causes include11 Cowper’s some gland illnesses such problems? as diabetes, some 12typesEjaculatory of surgery duct or trauma, some types of inflammation or infection, certain Premature ejaculation is the most common male medicines, and chemical imbalances in the brain sexual problem and affects men of all ages.
    [Show full text]
  • Aspermia: a Review of Etiology and Treatment Donghua Xie1,2, Boris Klopukh1,2, Guy M Nehrenz1 and Edward Gheiler1,2*
    ISSN: 2469-5742 Xie et al. Int Arch Urol Complic 2017, 3:023 DOI: 10.23937/2469-5742/1510023 Volume 3 | Issue 1 International Archives of Open Access Urology and Complications REVIEW ARTICLE Aspermia: A Review of Etiology and Treatment Donghua Xie1,2, Boris Klopukh1,2, Guy M Nehrenz1 and Edward Gheiler1,2* 1Nova Southeastern University, Fort Lauderdale, USA 2Urological Research Network, Hialeah, USA *Corresponding author: Edward Gheiler, MD, FACS, Urological Research Network, 2140 W. 68th Street, 200 Hialeah, FL 33016, Tel: 305-822-7227, Fax: 305-827-6333, USA, E-mail: [email protected] and obstructive aspermia. Hormonal levels may be Abstract impaired in case of spermatogenesis alteration, which is Aspermia is the complete lack of semen with ejaculation, not necessary for some cases of aspermia. In a study of which is associated with infertility. Many different causes were reported such as infection, congenital disorder, medication, 126 males with aspermia who underwent genitography retrograde ejaculation, iatrogenic aspemia, and so on. The and biopsy of the testes, a correlation was revealed main treatments based on these etiologies include anti-in- between the blood follitropine content and the degree fection, discontinuing medication, artificial inseminization, in- of spermatogenesis inhibition in testicular aspermia. tracytoplasmic sperm injection (ICSI), in vitro fertilization, and reconstructive surgery. Some outcomes were promising even Testosterone excreted in the urine and circulating in though the case number was limited in most studies. For men blood plasma is reduced by more than three times in whose infertility is linked to genetic conditions, it is very difficult cases of testicular aspermia, while the plasma estradiol to predict the potential effects on their offspring.
    [Show full text]
  • EAU Guidelines on Male Infertility$ W
    European Urology European Urology 42 (2002) 313±322 EAU Guidelines on Male Infertility$ W. Weidnera,*, G.M. Colpib, T.B. Hargreavec, G.K. Pappd, J.M. Pomerole, The EAU Working Group on Male Infertility aKlinik und Poliklinik fuÈr Urologie und Kinderurologie, Giessen, Germany bOspedale San Paolo, Polo Universitario, Milan, Italy cWestern General Hospital, Edinburgh, Scotland, UK dSemmelweis University Budapest, Budapest, Hungary eFundacio Puigvert, Barcelona, Spain Accepted 3 July 2002 Keywords: Male infertility; Azoospermia; Oligozoospermia; Vasectomy; Refertilisation; Varicocele; Hypogo- nadism; Urogenital infections; Genetic disorders 1. Andrological investigations and 2.1. Treatment spermatology A wide variety of empiric drug approaches have been tried (Table 1). Assisted reproductive techniques, Ejaculate analysis and the assessment of andrological such as intrauterine insemination, in vitro fertilisation status have been standardised by the World Health (IVF) and intracytoplasmic sperm injection (ICSI) are Organisation (WHO). Advanced diagnostic spermato- also used. However, the effect of any infertility treat- logical tests (computer-assisted sperm analysis (CASA), ment must be weighed against the likelihood of spon- acrosome reaction tests, zona-free hamster egg penetra- taneous conception. In untreated infertile couples, the tion tests, sperm-zona pellucida bindings tests) may be prediction scores for live births are 62% to 76%. necessary in certain diagnostic situations [1,2]. Furthermore, the scienti®c evidence for empirical approaches is low. Criteria for the analysis of all therapeutic trials have been re-evaluated. There is 2. Idiopathic oligoasthenoteratozoospermia consensus that only randomised controlled trials, with `pregnancy' as the outcome parameter, can accepted Most men presenting with infertility are found to for ef®cacy analysis. have idiopathic oligoasthenoteratozoospermia (OAT).
    [Show full text]
  • Male Sexual Dysfunction and Infertility Associated with Neurological Disorders Mikkel Fode University of Copenhagen
    Florida International University FIU Digital Commons Department of Psychology College of Arts, Sciences & Education 1-2012 Male sexual dysfunction and infertility associated with neurological disorders Mikkel Fode University of Copenhagen Sheila Krogh-Jespersen Department of Psychology, Florida International University Nancy L. Beckett University of Miami Dana A. Ohl University of Michigan Charles M. Lynn University of Miami See next page for additional authors Follow this and additional works at: https://digitalcommons.fiu.edu/psychology_fac Part of the Psychology Commons Recommended Citation Asian Journal of Andrology (2012) 14, 61–68; doi:10.1038/aja.2011.70; This work is brought to you for free and open access by the College of Arts, Sciences & Education at FIU Digital Commons. It has been accepted for inclusion in Department of Psychology by an authorized administrator of FIU Digital Commons. For more information, please contact [email protected]. Authors Mikkel Fode, Sheila Krogh-Jespersen, Nancy L. Beckett, Dana A. Ohl, Charles M. Lynn, and Jens Sønksen This article is available at FIU Digital Commons: https://digitalcommons.fiu.edu/psychology_fac/5 Asian Journal of Andrology (2012) 14, 61–68 ß 2012 AJA, SIMM & SJTU. All rights reserved 1008-682X/12 $32.00 www.nature.com/aja REVIEW Male sexual dysfunction and infertility associated with neurological disorders Mikkel Fode1, Sheila Krogh-Jespersen2, Nancy L Brackett3, Dana A Ohl4, Charles M Lynne5 and Jens Sønksen1 Normal sexual and reproductive functions depend largely on neurological mechanisms. Neurological defects in men can cause infertility through erectile dysfunction, ejaculatory dysfunction and semen abnormalities. Among the major conditions contributing to these symptoms are pelvic and retroperitoneal surgery, diabetes, congenital spinal abnormalities, multiple sclerosis and spinal cord injury.
    [Show full text]
  • Evaluation Prior to Sperm Retrieval
    Medical Economics 10.14.03 16:17 Date Relevance Search Advanstar Medical Economics Magazines | Search Tips Contemporary OB/GYN® Archive April 15, 1997 Sperm retrieval for assisted reproductive technologies Jump Choose article section... Go to: Ejaculated or surgically retrieved spermatozoa, including immature sperm retrieved from the epididymis and testis, may be used for intracytoplasmic sperm injection. By Yefim Sheynkin, MD, Peter N. Schlegel, MD One in every six married couples in the US will seek medical evaluation for assistance with fertility, and in up to 50% of couples a male factor is identified. The most severe expression of male factor infertility is azoospermia, where no sperm are present in the ejaculate. Causes of azoospermia include congenital and acquired reproductive tract obstruction as well as spermatogenic failure. Less than a decade ago, patients with azoospermia were often unable to be successfully treated. Since the introduction of intracytoplasmic sperm injection, treatment of most men with azoospermia can now be considered for treatment, even if the azoospermia is caused by testicular failure. 1 2 Intracytoplasmic sperm injection (ICSI), a technique performed as part of an in vitro fertilization (IVF) cycle, has revolutionized the treatment of severe male factor infertility. ICSI involves the injection of a single sperm into each oocyte, in vitro, during an IVF cycle. ICSI essentially bypasses all natural barriers to fertilization, such as sperm interaction with the zona pellucida and sperm-egg fusion. As long as there is sperm viability, fertilization rates with ICSI will be comparable with those achieved during IVF with normal spermatozoa. Subsequent pregnancy rates then depend primarily on female factors, emphasizing the tremendous value of ICSI in overriding specific sperm defects that heretofore may have limited treatment of severe male factor infertility.
    [Show full text]
  • See Anorgasmia Absent Ejaculation: See Anejaculation Adaptive Filter, 6
    Index A ultrasonography, 41 Absence of Orgasm: see Anorgasmia Beta-human chorionic gonadotropin, 193 Absent ejaculation: see Anejaculation Blue dot sign, 130 Adaptive filter, 6 Broadband transducer, 2 Addison disease, 328 selection, 5 Adenomatoid tumor, 160 handling, 5 MRI, 174 Broad-spectrum antibiotics, 95 ultrasonography, 174 Bulbourethral glands AdrenoCorticoTropic hormone (ACTH), 236, 285, 328 infection, 93 Adrenogenital syndrome, 328 parasitic, 113 Acute appendicitis, 122 non infection inflammation, 112 Androgen deficiency, 36, 303, 304 insensitivity syndrome, 286 C replacement factors, 210 Calcifications, 313 Androtest, 232 associated with cystic masses, 317 Anejaculation, 13, 36, 37 associated with solid masses, 317 Anorchidism, 34 MRI, 330 Anorgasmia, 37 ultrasonography, 330 Anosmia, 209 extra-testicular, 318 Antisperm antibodies, 211, 213 isolated and macroscopic, 318 Aromatase activity, 210 Carcinoma in situ (CIS), 314 Arteriography, 295 echopattern, 316 Arteriovenous fistula, 82 CEUS: see Contrast-enhanced ultrasonography Asthenospermia, 212 Chlamydia, 88, 211 Azoospermia, 208, 210, 241, 249, 292 Choriocarcinoma, 152, 168 factors regions (AZF), 234, 249 imaging, 168 non-obstructive (NOA), 234, 249–250, 255, 256 Coded transmission, 6 management, 249 Collection of the semen sample, 218 sperm retrival, 251 Colour Doppler Ultrasonography limits, 116 testis histology predominant patterns, 249 Complete Androgen Insensitivity Syndrome (CAIS) , 233 obstructive, 212 Computer Aided Sperm Analysis (CASA system), 219 clinical presentation, 242 Congenital adrenal hyperplasia, 285, 328 imaging, 275 Congenital testicular adrenal rest, 329 management, 242 MRI, 324 treatment options, 242 ultrasonography, 324 Coni vasculosi, 30 Contrast-enhanced ultrasonography: B see also Scrotal -enhanced ultrasonography Bag of worms: see also Varicocele, 144 complex cystic lesions, 348 Banking sperm, 152 contrast agents, 344 Behcet’s disease, 113 high degree testicular torsion, 345 Bell clapper deformity, 49 inflammation, 350 MRI, 163 low degree testicular torsion, 346 M.
    [Show full text]
  • Different Types of Azoospermia L
    Hormone levels in serum and seminal plasma of men with different types of azoospermia L. C. Garc\l=i'\aD\l=i'\ez,J. M. Gonzalez Buitrago, J. J. Corrales, E. Battaner and J. M. Miralles Servicio de Endocrinología, 'fServicio de Bioquímica, Hospital Clínico Universitario, Salamanca, y *Servicio de Análisis Clínicos, Residencia Sanitaria de la Seguridad Social Virgen de la Vega, Salamanca, Spain Summary. Hormone concentrations in the serum and seminal plasma of 15 normozoospermic, 17 excretory azoospermic and 14 secretory azoospermic men were measured. The results indicate that: (a) serum FSH and LH levels are markedly elevated in secretory azoospermia, as compared with excretory azoospermia and normozoospermia; (b) serum 17\g=a\-hydroxyprogesteronelevels are somewhat raised in secretory azoospermia as compared with excretory azoospermia and normozo- ospermia; (c) serum testosterone levels are lower in both types of azoospermia with respect to normozoospermia; (d) in secretory azoospermia the oestradiol serum levels are relatively high and dihydrotestosterone serum levels relatively low, whereas the serum levels of these hormones in excretory azoospermia are similar to those in normo- zoospermic men; (e) in the seminal plasma of azoospermic patients the levels of prolactin, progesterone, testosterone, dihydrotestosterone and oestradiol were de- pressed, but only dihydrotestosterone levels could be of value in differentiating types of azoospermia because they are lower in secretory azoospermia. We suggest that the measurement of FSH, LH, 17\g=a\-hydroxyprogesterone,dihydro- testosterone and oestradiol in serum and dihydrotestosterone in seminal plasma may be used in the differential diagnosis between secretory and excretory azoospermia when invasive tests are unavailable. Introduction Male infertility can usually be diagnosed by testicular biopsy, spermiography and sometimes vaso- graphy.
    [Show full text]
  • Sex and the Prostate
    Sex and the Prostate Seek Help! Erection problems aren’t ‘all in the mind’. One quarter of men treated for localised prostate cancer with radiotherapy can experience erection problems. If you suffer from prostate disease and are concerned about how this could affect your relationship with your partner, seek help. Don’t worry about talking to your doctor or nurse about your sex life – they want to help and they understand that it is important to you – it’s natural. This leaflet is for men with prostate disease and their partners, who may want to find out more about sexual problems so that they can continue to enjoy or, indeed, return to an intimate and fulfilling sex life. Sex and the prostate – two ‘intimate’ subjects At whatever stage in life, sex is an Prostate Bladder important part of an intimate and happy relationship for most couples. A disappointing or unfulfilling sex life can often damage a relationship, leaving either partner with a feeling of loneliness, insecurity and often too embarrassed to seek help and/or to start a new relationship. Although not typically described as a sexual problem, prostate disease and particularly its treatment, can be linked to, or be the cause of sexual problems in men. This booklet aims to explain some of the main reasons for this. The prostate gland is part of the male genito-urinary system. It is a small organ that lies just below a man's bladder. It surrounds the urethra, the tube that carries urine from the bladder out of the body through the penis.
    [Show full text]